The IDUA gene gives your body instructions to make an enzyme that helps clear certain complex sugars from the cell’s recycling system. When this gene does not work properly, those sugars build up and cause mucopolysaccharidosis type I, a condition that can affect growth, joints, bones, breathing, the heart, hearing, vision, and sometimes learning. Severity varies, with some people having milder symptoms and others developing more widespread health problems in early childhood.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
IDUAGene function
What if the gene works
The IDUA gene helps make an enzyme that breaks down certain natural sugars inside cell recycling centers. This supports normal tissue growth and helps prevent buildup in organs, bones, joints, and the brain.
Risk
What if the gene does not work
Variants in the IDUA gene can cause mucopolysaccharidosis type I, with a range from milder later-onset forms to more severe early childhood disease. Common effects include coarse facial features, stiff joints, growth and heart problems, clouded corneas, and developmental delay.
Treatment
What does that mean for your treatment
Pathogenic variants in the IDUA gene can make a person eligible for laronidase enzyme replacement therapy. In severe early-onset forms, stem cell transplant is often considered early because it can better protect brain function than enzyme treatment alone. The exact IDUA variant usually does not determine the drug choice.
Conditions associated with IDUA
Gene function
What if the gene works
Your cells are always clearing away used materials. The IDUA gene helps with that cleanup by supporting the breakdown of glycosaminoglycans (long sugar chains found in many tissues). This work happens mainly in lysosomes (the cell’s recycling centers), helping normal tissue turnover.
The IDUA gene helps cells take apart two long sugar chains, called dermatan sulfate and heparan sulfate, that are used throughout the body. Its enzyme removes a specific sugar piece so these chains can be broken down step by step.
This enzyme works inside lysosomes (the cell’s recycling centers), where worn out materials are dismantled. By handling one key step in that process, it supports steady cell housekeeping.
Many tissues regularly replace parts of their supportive material during everyday wear and repair. The IDUA gene helps that normal turnover stay balanced by clearing older sugar chains as new ones are made.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IDUA gene can lower or block production of alpha-L-iduronidase, an enzyme that helps cells break down certain complex sugars. Some variants severely disrupt the protein so little or no enzyme reaches the cell’s recycling centers, while milder changes leave partial activity. This range helps explain how IDUA gene variants affect enzyme function and why MPS I can appear earlier and be more pronounced in some people than in others.
How variants are linked to conditions
Pathogenic variants in both copies of the IDUA gene cause mucopolysaccharidosis type I, often shortened to MPS I. This IDUA gene condition ranges from a more severe early childhood form to milder forms that may be recognized later. Historically, this spectrum was called Hurler syndrome, Hurler-Scheie syndrome, and Scheie syndrome. A variant in one copy of the IDUA gene usually means carrier status, not the condition itself.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For IDUA, risk is mainly shaped by genetics rather than lifestyle. A child develops the condition when both copies of the IDUA gene are changed, so risk is higher if both parents carry a harmful variant; family history and ancestry groups with more carriers can also raise the chance.
Inheritance of IDUA variants
Variants in the IDUA gene linked to mucopolysaccharidosis type I are inherited in an autosomal recessive pattern. This means a child inherits one nonworking copy of the IDUA gene from each parent. Parents who each carry one variant usually do not have the condition themselves, but with each pregnancy there is a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit two working copies. In families asking how IDUA gene variants are inherited, this pattern means boys and girls are affected equally.
What does my IDUA result mean for my family?
For IDUA, family members can be affected mainly in families where both parents carry a changed copy of the gene. Brothers and sisters may also have the condition or be carriers, even if they seem well. Parents are usually healthy carriers, and other close relatives may be carriers too, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the IDUA gene, genetic testing for IDUA variants uses a blood or saliva sample to read the gene's DNA. It can identify the specific variant present and may help clarify whether a person has, or is a carrier for, a condition linked to this gene.
When should I consider getting a genetic test?
Consider IDUA genetic testing if a child has signs of a rare inherited condition called MPS I, such as frequent hernias, stiff joints, cloudy eyes, growth problems, or delayed development, or if newborn screening suggests it. Testing can also help when MPS I runs in your family or for carrier and pregnancy planning.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. How the body works over time is also shaped by many factors, including age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles certain medicines. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else. Differences in how the body breaks down, moves, or responds to a drug are common and can affect both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By looking at connections between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the IDUA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so general questions about medicines, side effects, or your health are best discussed with your doctor.
History
Throughout history, people have described features that hinted at this gene. In the early 1900s, physicians began reporting children with what is now recognized as mucopolysaccharidosis type I, first described as Hurler syndrome and later understood to include related forms such as Scheie syndrome. Inheritance patterns were noticed long before the IDUA gene was identified. By the late 20th century, researchers linked these conditions to changes in alpha-L-iduronidase and then mapped the responsible gene, the IDUA gene, to chromosome 4. That discovery helped unite several previously separated diagnoses under one genetic cause. From these first observations, research expanded steadily, shaping newborn screening, enzyme replacement therapy, and later gene therapy studies for IDUA-related disease.